Valisha Edwards is a dedicated Access Reimbursement Manager and Field Training Mentor at Teva Pharmaceuticals / Cover My Meds, where she leverages her extensive expertise in healthcare reimbursement and patient support services to enhance patient access to critical therapies. In her current role, Valisha plays...
Valisha Edwards is a dedicated Access Reimbursement Manager and Field Training Mentor at Teva Pharmaceuticals / Cover My Meds, where she leverages her extensive expertise in healthcare reimbursement and patient support services to enhance patient access to critical therapies. In her current role, Valisha plays a pivotal part in mentoring newly hired Access Reimbursement Managers, ensuring they are well-equipped to navigate the complexities of reimbursement processes. Her commitment to education is evident as she provides ongoing training and support, fostering a culture of continuous learning and professional development within her team.
Valisha's involvement on the Field Advisory Board underscores her proactive approach to addressing and resolving reimbursement issues that impact patient access. She collaborates with cross-functional teams to analyze access reimbursement challenges, utilizing her strong analytical skills to develop effective strategies that optimize reimbursement pathways. Her deep understanding of the insurance landscape, including Medicare Advantage and managed care, enables her to advocate effectively for patients and healthcare providers alike.
In addition to her technical expertise, Valisha excels in interpersonal skills, employing motivational interviewing techniques to engage patients and healthcare professionals in meaningful conversations about access to therapies. Her ability to deliver compelling sales presentations and conduct informative training sessions positions her as a trusted resource in the field. Valisha Edwards embodies a commitment to improving patient outcomes through education, mentorship, and strategic problem-solving, making her an invaluable asset to Teva Pharmaceuticals and the broader healthcare community.
